# Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology

> **NCT01829646** · NA · UNKNOWN · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 120 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **OTHER:** functional MRI
- **OTHER:** Hypoxia gene expression profile.
- **OTHER:** Functional MRI before start of treatment.

## Key facts

- **NCT ID:** NCT01829646
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01829646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01829646, "Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01829646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*